Tuesday, January 24, 2012

FzioMed Receives CE Mark for DYNAVISC® Gel

FzioMed Receives CE Mark for DYNAVISC® Gel
New Adhesion Barrier Gel for Tendon and Peripheral Nerve Surgery

January 23, 2012 09:03 AM Eastern Time
SAN LUIS OBISPO, Calif.--(EON: Enhanced Online News)--FzioMed, Inc. is pleased to announce that it has received CE Mark approval to market DYNAVISC® adhesion barrier gel in Europe for tendon and peripheral nerve surgery.

DYNAVISC is a clear, absorbable gel supplied ready-to-use in a 1mL syringe. It is designed to coat tissues during tendon and peripheral nerve surgery. DYNAVISC gel acts as a temporary, protective barrier that separates tissues and reduces fibrosis and the formation of post-surgical adhesions.
DYNAVISC was developed by FzioMed and is based on the Company’s world-leading anti-adhesion biomaterial technology.

Adhesions are internal bands of scar tissue that can develop following surgery as the body attempts to heal. Adhesions tether tissues and surfaces that are normally not connected, later causing pain, nerve compression and impaired motion. Adhesions are a significant complication of many surgical procedures and a prevalent cause of post-surgical morbidity.

“Well over a million procedures to repair tendons are performed in the EU each year and one-third of traumatic injuries involve damage to tendons and nerves,” said John Krelle, President & CEO of FzioMed. “Adhesions can impact an otherwise successful procedure, leaving a patient with pain and diminished quality of life.”

Complete press release click here:

No comments: